Back to User profile » Dr Masahiro Mizoguchi
Papers published by Dr Masahiro Mizoguchi:
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017
Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2016, 9:7123-7131
Published Date: 17 November 2016
Molecular biomarkers of glioblastoma: current targets and clinical implications
Yoshimoto K, Mizoguchi M, Hata N, Amano T, Nakamizo A, Sasaki T
Current Biomarker Findings 2012, 2:63-76
Published Date: 4 September 2012